amyloid-beta measurement (Experimental Factor Ontology entry EFO_0005194) is quantification of the amyloid-beta, either in a sample of cerebro-spinal fluid or via PET scan, used as a biomarker for Alzheimer's disease. Also known as: Ab measurement, cortical Ab measurement.